| 查看: 429 | 回复: 3 | |||
[交流]
有虫子知道Adhaere Pharmaceuticals, Inc.这家公司吗 已有1人参与
|
| 好像很神秘 |
» 猜你喜欢
祝基金高中
已经有25人回复
维普求助
已经有0人回复
药理学论文润色/翻译怎么收费?
已经有53人回复
求计算药动学参数
已经有0人回复
丙酮酸激酶的抑制剂和激动剂
已经有1人回复
医药研发数据库资源
已经有2人回复
1949stone
荣誉版主 (知名作家)
海纳百川
- 应助: 95 (初中生)
- 贵宾: 2.38
- 金币: 2480.1
- 散金: 3394
- 红花: 177
- 沙发: 8
- 帖子: 9847
- 在线: 2693.7小时
- 虫号: 765987
- 注册: 2009-05-08
- 性别: GG
- 专业: 药物分析
- 管辖: 分子生物

2楼2014-02-20 10:22:42
1949stone
荣誉版主 (知名作家)
海纳百川
- 应助: 95 (初中生)
- 贵宾: 2.38
- 金币: 2480.1
- 散金: 3394
- 红花: 177
- 沙发: 8
- 帖子: 9847
- 在线: 2693.7小时
- 虫号: 765987
- 注册: 2009-05-08
- 性别: GG
- 专业: 药物分析
- 管辖: 分子生物
|
Adhaere Pharmaceuticals, Inc is a new, privately held, company developing novel small molecule therapeutics for the treatment of cancer and inflammatory and autoimmune diseases. The company's innovative approach focuses on a unique way of targeting adhesion receptors on leukocytes. Adhaere has also created a broadly applicable proprietary technology platform for the discovery of a pipeline of novel therapeutics. Specialties Pharmaceutical, Research and Development, Immunology, Inflammation, Autoimmune Diseases, Breast Cancer, Cancer, Small Molecule Drug Discovery, Biotech, Leukocytes, Intergrin CD11b/CD18, Multiple Sclerosis, Arthritis, Lupus |

3楼2014-02-20 10:22:55
4楼2014-02-21 11:42:39












回复此楼